Fig. 4
From: PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Associating Immune Scores with Patient Survival. A Skin Cancer Patients treated with ICI dichotemized based on xCell derived Immune Scores as well as M2 Macrophage estimated from Cibersort. Patients with High Immune Score and Low M2 Macrophage were associated with better survival. B User Interface that access this function from the Shiny App is (1) Select Feature Condition to restrict to pretreated patients, (2) Multivariate Coxh Analysis, (3) Bivariate Interaction Survival Analysis, (4) Select Immune Score (on left) and M2 Macrophage (on right). The feature can be dichotemized “on-the-fly” if it is a continuous variable (4)